조사회사 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2024년07월
Specialty Enzymes Market – Global Forecast to 2029
특수 효소 시장 : 출처 (미생물, 식물, 동물), 유형 (탄수화물 분해효소, 프로테아제, 리파제, 중합효소 및 뉴클레아제), 용도 (의약품, 진단, 연구 및 생명공학), 형식 및 지역 – 2029년까지의 세계 예측
Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region – Global Forecast to 2029
| 페이지 수 | 295 |
| 도표 수 | 367 |
| 가격 | |
| Single User License | USD 4,950 |
| Multi User License | USD 6,650 |
| Corporate License | USD 8,150 |
| Enterprise License | USD 10.000 |
| 구성 | 영문조사보고서 |
Report Overview
According to MarketsandMarkets, the global Specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%, during the forecast period in terms of value.
MarketsandMarkets에 따르면 세계 특수 효소 시장 규모는 2024년에 61억 달러로 추정되며, 2029년까지 92억 달러에 도달할 것으로 예측되며, 금액 예측 기간 동안 8.5%의 CAGR을 기록합니다.
Their ability to cleave complex carbohydrates on biomolecules holds immense potential for developing highly specific diagnostic tools. For instance, carbohydrases can be used to target specific sugar signatures on pathogens, enabling rapid and accurate identification of infectious diseases. Additionally, they can be employed to analyze specific carbohydrate markers associated with certain illnesses, aiding in earlier and more precise diagnoses. As the focus on personalized medicine intensifies, carbohydrases offer a unique edge in developing diagnostics that cater to individual needs, solidifying their prominence in the future of diagnostic testing.
” By source, Microorganisms are estimated to dominate the market during the forecast period.”
Microorganisms reign supreme in the source category of the specialty enzyme market due to their ideal qualities for various applications, particularly in research & biotechnology. Microbes like bacteria and fungi can be easily cultivated in controlled environments, allowing for scalable and cost-effective production of large enzyme quantities. This is crucial for research where consistent enzyme supplies are needed for experiments. The vast genetic diversity of microbes offers a treasure trove of enzymes with highly specific functions. Scientists can harness these enzymes to manipulate biomolecules with incredible precision, a necessity in research & biotechnology. For example, microbial enzymes can be used to selectively cut specific sections of DNA, facilitating gene editing techniques vital for creating new treatments and therapies. Furthermore, microbes can be genetically modified to create enzymes with novel properties, further expanding their potential in research endeavors. This unmatched versatility and adaptability solidify microorganism-derived enzymes as the leading source for the specialty enzyme market in research & biotechnology.
“Europe will significantly contribute towards market growth during the forecast period.”
Europe boasts a well-established healthcare infrastructure with strong government support for specialty enzyme industries. This translates to a high demand for innovative medical treatments, including those that utilize specialty enzymes. Europe’s aging population creates a market for enzyme-based therapies for chronic diseases. Additionally, there’s a growing focus on sustainable practices, and specialty enzymes offer a more eco-friendly alternative to traditional chemical catalysts in various industries. Furthermore, collaborations between European enzyme manufacturers and research institutions are accelerating market growth. For instance, According to CORDIS – EU research results, starting in December 2023, the EU-funded FuturEnzyme project aims to develop low-cost enzymes for eco-friendly consumers. Through innovative solutions and collaborative efforts, it will receive approximately USD 6.7 billion for enzyme discovery and optimization until May 2025.
Break-up of Primaries:
By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%
By Designation: C-level-45%, D-level – 33%, and Others- 22%
By Region: North America – 15%, Europe – 20%, Asia Pacific – 40%, South America-12%, RoW – 13%,
Others include sales managers, territory managers, and product managers.
Leading players profiled in this report:
• BRAIN Biotech AG (Germany)
• Novozymes A/S (Denmark)
• Codexis, Inc. (US)
• Sanofi (France)
• Merck KGaA (Germany)
• Dyadic International Inc (US)
• Advanced Enzyme Technologies (India)
• Amano Enzyme Inc (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• New England Biolabs (US)
• BBI Solutions (UK)
• Creative Enzymes (US)
• Bioseutica (Netherland)
• SEKISUI Diagnostics (US)
• Antozyme Biotech Pvt Ltd (India)
• S.I. Biozyme (India)
• Aumgene Biosciences (India)
• enzymebiosciences (India)
• Infinita Biotech Private Limited (India)
• Biolaxi Corporation (India)
• Fido Pharma Pvt. Ltd. (India)
• 4basebio (UK)
• Ansel Biotech (India)
• Geno Technology Inc. (US)
• Gujarat Enzyme (India)
The study includes an in-depth competitive analysis of these key players in the specialty enzymes market with their company profiles, recent developments, and key market strategies.
Research Coverage:
The report segments the specialty enzymes market based on type, source, form, applications, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global specialty enzymes market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall specialty enzymes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics), restraints (Lack of Harmonization in the Regulatory Framework), opportunities (Lack of Harmonization in the Regulatory Framework), and challenges (Lack of Harmonization in the Regulatory Framework) influencing the growth of the specialty enzymes market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the specialty enzymes market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the specialty enzymes market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the specialty enzymes market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), and Advanced Enzyme Technologies (India) among others in the specialty enzymes market strategies. The report also helps stakeholders understand the specialty enzymes market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.3 STUDY SCOPE 42
FIGURE 1 MARKET SEGMENTATION 42
1.3.1 REGIONS COVERED 42
1.4 YEARS CONSIDERED 43
1.5 CURRENCY CONSIDERED 43
TABLE 1 USD EXCHANGE RATES, 2020–2023 43
1.6 UNIT CONSIDERED 44
1.7 STAKEHOLDERS 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 47
2.1.2.1 Key data from primary sources 47
2.1.2.2 Key industry insights 48
2.1.2.3 Breakdown of primary interviews 49
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION 49
2.2 FACTOR ANALYSIS 50
2.2.1 INTRODUCTION 50
2.2.2 DEMAND-SIDE ANALYSIS 50
FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020–2023 (USD BILLION) 50
2.2.3 SUPPLY-SIDE ANALYSIS 51
FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION) 51
2.3 MARKET SIZE ESTIMATION 52
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION) 52
2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET) 53
2.4 DATA TRIANGULATION 54
FIGURE 6 DATA TRIANGULATION METHODOLOGY 54
2.5 RESEARCH ASSUMPTIONS 55
2.6 LIMITATIONS & RISK ASSESSMENT 56
2.7 RECESSION IMPACT ANALYSIS 56
2.7.1 MACRO-INDICATORS OF RECESSION 56
FIGURE 7 RECESSION INDICATORS 56
FIGURE 8 GLOBAL INFLATION RATE, 2013–2023 57
FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013–2023 (USD TRILLION) 58
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET 59
FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST 59
3 EXECUTIVE SUMMARY 61
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029 61
FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 62
FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 62
FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 63
FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT 64
4 PREMIUM INSIGHTS 66
4.1 OPPORTUNITIES FOR PLAYERS IN SPECIALTY ENZYMES MARKET 66
FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES 66
4.2 SPECIALTY ENZYMES MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS 66
FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023 66
4.3 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE & KEY COUNTRY 67
FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024 67
4.4 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE 67
FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 67
4.5 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION 68
FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 68
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INCREASE IN RETAIL SALES 69
FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018–2023 (USD BILLION) 70
5.2.2 GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA 70
FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022 71
5.3 MARKET DYNAMICS 71
FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.3.1 DRIVERS 72
5.3.1.1 Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics 72
5.3.1.2 Supportive government policies and funding 72
5.3.1.3 Advanced tools to optimize pharmaceutical production 73
FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000–2022 (USD MILLION) 74
5.3.2 RESTRAINTS 74
5.3.2.1 Lack of harmonization in regulatory framework 74
5.3.2.2 High costs associated with specialty enzymes 75
5.3.3 OPPORTUNITIES 75
5.3.3.1 Rising significance of catalysts in pharmaceutical industry 75
5.3.3.2 Technological innovations and wide industry scope 76
FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017–2023 (USD BILLION) 76
5.3.3.3 Development of enzymes with long shelf life 77
5.3.3.4 Need for encapsulation to enhance shelf life of enzymes 77
5.3.3.5 Utilization of plant biomass for production of specialty enzymes 77
5.3.4 CHALLENGES 78
5.3.4.1 High research and development costs 78
5.3.4.2 Competition from alternative technologies or products 78
6 INDUSTRY TRENDS 80
6.1 INTRODUCTION 80
6.2 SUPPLY CHAIN ANALYSIS 80
FIGURE 26 SUPPLY CHAIN ANALYSIS 81
6.3 VALUE CHAIN ANALYSIS 81
FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS 82
6.4 TRADE ANALYSIS 82
6.4.1 EXPORT SCENARIO OF SPECIALTY ENZYMES 82
FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND) 83
TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND) 83
6.4.2 IMPORT SCENARIO OF SPECIALTY ENZYMES 83
FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND) 84
TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND) 84
6.5 TECHNOLOGY ANALYSIS 84
6.5.1 KEY TECHNOLOGIES 84
6.5.1.1 Protein engineering for drug delivery 84
6.5.1.2 Next-Generation Sequencing (NGS) for enzyme-based diagnostics 85
6.5.1.3 Directed evolution of enzymes 85
6.5.2 ADJACENT TECHNOLOGIES 85
6.5.2.1 Food enzymes immobilization 85
6.6 PRICING ANALYSIS 86
6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION 86
FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022–2023 (USD/KG) 86
TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020–2023 (USD/KG) 87
6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION 87
FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG) 87
TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 (USD/KG) 88
6.7 ECOSYSTEM 88
6.7.1 SUPPLY SIDE 88
6.7.2 DEMAND SIDE 88
FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM 89
TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM 89
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90
FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 90
6.9 PATENT ANALYSIS 90
FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET 91
TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020–2024 91
6.10 KEY CONFERENCES & EVENTS, 2024–2025 93
TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024–2025 93
6.11 REGULATORY LANDSCAPE 94
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
6.11.2 REGULATIONS, BY REGION 96
6.11.2.1 North America 96
6.11.2.1.1 US 96
6.11.2.1.2 Canada 96
6.11.2.2 Europe 96
6.11.2.2.1 European Union 96
6.11.2.3 Asia Pacific 96
6.11.2.3.1 China 96
6.11.2.3.2 India 96
6.11.2.4 South America 97
6.11.2.4.1 Brazil 97
6.12 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 14 SPECIALTY ENZYMES MARKET: PORTER’S FIVE FORCES ANALYSIS 97
6.12.1 INTENSITY OF COMPETITIVE RIVALRY 97
6.12.2 BARGAINING POWER OF SUPPLIERS 97
6.12.3 BARGAINING POWER OF BUYERS 98
6.12.4 THREAT OF SUBSTITUTES 98
6.12.5 THREAT OF NEW ENTRANTS 98
6.13 KEY STAKEHOLDERS & BUYING CRITERIA 99
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES 99
TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES 99
6.13.2 BUYING CRITERIA 99
TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS 100
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS 100
6.14 CASE STUDIES 101
6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS 101
6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES 101
6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE 102
6.15 INVESTMENT AND FUNDING SCENARIO 102
FIGURE 37 INVESTMENT AND FUNDING SCENARIO 102
7 SPECIALTY ENZYMES MARKET, BY TYPE 103
7.1 INTRODUCTION 104
FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 104
TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 105
TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 105
TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (KILOTONS) 106
TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (KILOTONS) 106
7.2 CARBOHYDRASES 106
7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH 106
TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 107
TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 107
TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 107
TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 108
TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 108
TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 108
7.2.2 AMYLASES 109
TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 109
TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 109
7.2.3 CELLULASES 109
TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 110
TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 110
7.2.4 OTHER CARBOHYDRASES 110
TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 111
TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 111
7.3 PROTEASES 111
7.3.1 INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET 111
TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 112
TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 112
TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 112
TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 113
7.4 LIPASES 113
7.4.1 USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET 113
TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 113
TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 114
TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 114
TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 114
7.5 POLYMERASES & NUCLEASES 115
7.5.1 PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH 115
TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 115
TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 116
TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 116
TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 116
7.6 OTHER ENZYMES 117
TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS 117
TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 118
TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 118
TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 118
TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 119
8 SPECIALTY ENZYMES MARKET, BY FORM 120
8.1 INTRODUCTION 120
8.2 LIQUID 120
8.2.1 NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES 120
8.3 DRY 121
8.3.1 ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH 121
FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES 121
9 SPECIALTY ENZYMES MARKET, BY SOURCE 122
9.1 INTRODUCTION 123
FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 123
TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 124
TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 124
9.2 MICROORGANISMS 124
9.2.1 NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET 124
TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 125
TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 125
9.3 PLANTS 125
9.3.1 ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT 125
TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 126
TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 126
9.4 ANIMALS 127
9.4.1 ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES 127
TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 127
TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 128
10 SPECIALTY ENZYMES MARKET, BY APPLICATION 129
10.1 INTRODUCTION 130
FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 130
TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 130
TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 131
10.2 PHARMACEUTICALS 131
10.2.1 INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET 131
TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 132
TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 132
TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 133
TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 133
10.3 RESEARCH & BIOTECHNOLOGY 133
10.3.1 DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET 133
TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 134
TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 134
TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 135
TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 135
10.4 DIAGNOSTICS 136
10.4.1 SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH 136
TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 136
TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 137
TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 137
TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 138
10.5 BIOCATALYSTS 138
10.5.1 BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES 138
TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 139
TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 139
TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 139
TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 140
11 SPECIALTY ENZYMES MARKET, BY REGION 141
11.1 INTRODUCTION 142
FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD 142
TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (USD MILLION) 143
TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (USD MILLION) 143
TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020–2023 (KILOTONS) 143
TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024–2029 (KILOTONS) 144
11.2 NORTH AMERICA 144
FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT 145
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 145
FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2022 146
FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 146
TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 147
TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 147
TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 147
TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 148
TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 148
TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 148
TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 148
TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 149
TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 149
TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 149
11.2.2 US 149
11.2.2.1 Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market 149
TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 150
TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 150
TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 151
TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 151
11.2.3 CANADA 151
11.2.3.1 Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics 151
TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 152
TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 152
TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 152
TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 153
11.2.4 MEXICO 153
11.2.4.1 Need for detecting changes in substrate concentrations to boost market growth 153
TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 154
TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 154
TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 154
TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 155
11.3 EUROPE 155
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 156
FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2022 156
FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023 157
TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 157
TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 158
TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 158
TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 158
TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 159
TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 159
TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 159
TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 159
TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 160
TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 160
11.3.2 ITALY 160
11.3.2.1 Rise in production of pharmaceuticals to drive demand for specialty enzymes 160
TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 161
TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 161
TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 161
TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 162
11.3.3 GERMANY 162
11.3.3.1 Rapid technological advancements in pharmaceuticals sector to boost growth 162
TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 162
TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 163
TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 163
TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 163
11.3.4 FRANCE 164
11.3.4.1 Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes 164
TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 164
TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 164
TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 165
TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 165
11.3.5 SPAIN 165
11.3.5.1 Spanish government’s emphasis on developments in pharmaceutical industry to boost enzymes market 165
TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 166
TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 166
TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 166
TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 167
11.3.6 UK 167
11.3.6.1 Increased use of enzymes in drug cloning technique to spur demand 167
TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 167
TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 168
TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 168
TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 168
11.3.7 DENMARK 169
11.3.7.1 Growing export of enzymes to propel demand for specialty enzymes 169
TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 169
TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 169
TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 170
TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 170
11.3.8 NETHERLANDS 170
11.3.8.1 Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes 170
TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 171
TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 171
TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 171
TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 172
11.3.9 REST OF EUROPE 172
TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 172
TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 173
TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 173
TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 173
11.4 ASIA PACIFIC 174
FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT 175
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 175
FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2022 176
FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023 176
TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 177
TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 177
TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 177
TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 178
TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 178
TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 178
TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 178
TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 179
TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 179
TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 179
11.4.2 CHINA 179
11.4.2.1 Rapid technical advancements to augment demand for specialty enzymes 179
TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 180
TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 180
TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 181
TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 181
11.4.3 INDIA 181
11.4.3.1 Rising demand for specialty enzymes in pharmaceutical industry to boost market 181
TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 182
TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 182
TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 182
TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 183
11.4.4 JAPAN 183
11.4.4.1 Growing biotechnology advancements in Japan to augment demand for specialty enzymes 183
TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 184
TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 184
TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 184
TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 185
11.4.5 SOUTH KOREA 185
11.4.5.1 Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes 185
TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 185
TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 186
TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 186
TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 186
11.4.6 AUSTRALIA & NEW ZEALAND 187
11.4.6.1 Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes 187
TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 187
TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 187
TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 188
TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 188
11.4.7 REST OF ASIA PACIFIC 188
TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 189
TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 189
TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 189
TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 190
11.5 SOUTH AMERICA 190
11.5.1 SOUTH AMERICA: RECESSION IMPACT 190
FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018–2022 191
FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 191
TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 191
TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 192
TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 192
TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 192
TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 193
TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 193
TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 193
TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 193
TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 194
TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 194
11.5.2 BRAZIL 194
11.5.2.1 Thriving pharmaceutical industry to drive demand for enzymes 194
TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 195
TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 195
TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 195
TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 196
11.5.3 ARGENTINA 196
11.5.3.1 Government support in pharmaceuticals and research and development to boost growth 196
TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 196
TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 197
TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 197
TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 197
11.5.4 REST OF SOUTH AMERICA 197
TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 198
TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 198
TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 198
TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 199
11.6 REST OF THE WORLD 199
11.6.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS 199
FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017–2022 200
FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023 201
TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 201
TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 201
TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 202
TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 202
TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020–2023 (USD MILLION) 202
TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024–2029 (USD MILLION) 203
TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020–2023 (USD MILLION) 203
TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024–2029 (USD MILLION) 203
TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 204
TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 204
11.6.2 AFRICA 204
11.6.2.1 Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry 204
TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 205
TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 205
TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 205
TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 206
11.6.3 MIDDLE EAST 206
11.6.3.1 Government initiatives to promote biotechnological research and development to drive demand 206
TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 207
TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 207
TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020–2023 (USD MILLION) 207
TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024–2029 (USD MILLION) 208
12 COMPETITIVE LANDSCAPE 209
12.1 OVERVIEW 209
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 210
TABLE 218 OVERVIEW OF STRATEGIES ADOPTED BY KEY SPECIALTY ENZYME VENDORS 210
12.3 REVENUE ANALYSIS 212
FIGURE 55 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD MILLION) 212
12.4 MARKET SHARE ANALYSIS, 2023 213
FIGURE 56 SPECIALTY ENZYMES MARKET: DEGREE OF COMPETITION (CONSOLIDATED) 213
12.5 COMPANY VALUATION AND FINANCIAL METRICS 214
FIGURE 57 SPECIALTY ENZYMES MARKET: COMPANY VALUATION (USD BILLION) 214
FIGURE 58 EV/EBITDA OF KEY PLAYERS, 2023 214
12.6 BRAND/PRODUCT COMPARISON 215
FIGURE 59 SPECIALTY ENZYMES MARKET: BRAND/PRODUCT COMPARISON 215
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 216
12.7.1 STARS 216
12.7.2 EMERGING LEADERS 216
12.7.3 PERVASIVE PLAYERS 216
12.7.4 PARTICIPANTS 217
FIGURE 60 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 217
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 218
FIGURE 61 SPECIALTY ENZYMES MARKET: COMPANY FOOTPRINT 218
TABLE 219 SPECIALTY ENZYMES MARKET: REGIONAL FOOTPRINT 218
TABLE 220 SPECIALTY ENZYMES MARKET: TYPE FOOTPRINT 219
TABLE 221 SPECIALTY ENZYMES MARKET: APPLICATION FOOTPRINT 220
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 221
12.8.1 PROGRESSIVE COMPANIES 221
12.8.2 RESPONSIVE COMPANIES 221
12.8.3 DYNAMIC COMPANIES 221
12.8.4 STARTING BLOCKS 221
FIGURE 62 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 222
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 223
12.8.5.1 Detailed list of key startups/SMEs 223
TABLE 222 SPECIALTY ENZYMES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 223
12.8.5.2 Competitive benchmarking of key startups/SMEs 224
TABLE 223 SPECIALTY ENZYMES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 224
12.9 COMPETITIVE SCENARIO AND TRENDS 225
12.9.1 PRODUCT LAUNCHES 225
TABLE 224 SPECIALTY ENZYMES MARKET: PRODUCT LAUNCHES, DECEMBER 2021–FEBRUARY 2024 225
12.9.2 DEALS 226
TABLE 225 SPECIALTY ENZYMES MARKET: DEALS, FEBRUARY 2019–APRIL 2024 226
12.9.3 OTHERS 231
TABLE 226 SPECIALTY ENZYMES MARKET: OTHERS, MAY 2019–APRIL 2024 231
13 COMPANY PROFILES 234
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS 234
13.1.1 BRAIN BIOTECH AG 234
TABLE 227 BRAIN BIOTECH AG: BUSINESS OVERVIEW 234
FIGURE 63 BRAIN BIOTECH AG: COMPANY SNAPSHOT 235
TABLE 228 BRAIN BIOTECH AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235
TABLE 229 BRAIN BIOTECH AG: OTHERS 236
13.1.2 NOVOZYMES A/S 238
TABLE 230 NOVOZYMES A/S: BUSINESS OVERVIEW 238
FIGURE 64 NOVOZYMES A/S: COMPANY SNAPSHOT 239
TABLE 231 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239
TABLE 232 NOVOZYMES A/S: DEALS 240
TABLE 233 NOVOZYMES A/S: OTHERS 241
13.1.3 CODEXIS, INC. 242
TABLE 234 CODEXIS, INC.: BUSINESS OVERVIEW 242
FIGURE 65 CODEXIS, INC.: COMPANY SNAPSHOT 242
TABLE 235 CODEXIS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 243
TABLE 236 CODEXIS, INC.: PRODUCT LAUNCHES 243
TABLE 237 CODEXIS, INC.: DEALS 243
TABLE 238 CODEXIS, INC.: OTHERS 245
13.1.4 SANOFI 246
TABLE 239 SANOFI: BUSINESS OVERVIEW 246
FIGURE 66 SANOFI: COMPANY SNAPSHOT 247
TABLE 240 SANOFI: PRODUCTS/SOLUTIONS/SERVICES OFFERED 247
TABLE 241 SANOFI: DEALS 248
13.1.5 MERCK KGAA 249
TABLE 242 MERCK KGAA: BUSINESS OVERVIEW 249
FIGURE 67 MERCK KGAA: COMPANY SNAPSHOT 250
TABLE 243 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250
TABLE 244 MERCK KGAA: DEALS 251
TABLE 245 MERCK KGAA: OTHERS 251
13.1.6 DYADIC INTERNATIONAL INC. 253
TABLE 246 DYADIC INTERNATIONAL INC.: BUSINESS OVERVIEW 253
FIGURE 68 DYADIC INTERNATIONAL INC.: COMPANY SNAPSHOT 254
TABLE 247 DYADIC INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254
TABLE 248 DYADIC INTERNATIONAL INC.: DEALS 255
13.1.7 ADVANCED ENZYME TECHNOLOGIES 256
TABLE 249 ADVANCED ENZYME TECHNOLOGIES: BUSINESS OVERVIEW 256
FIGURE 69 ADVANCED ENZYME TECHNOLOGIES: COMPANY SNAPSHOT 257
TABLE 250 ADVANCED ENZYME TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257
TABLE 251 ADVANCED ENZYME TECHNOLOGIES: DEALS 258
13.1.8 AMANO ENZYME INC. 259
TABLE 252 AMANO ENZYME INC.: BUSINESS OVERVIEW 259
TABLE 253 AMANO ENZYME INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 259
TABLE 254 AMANO ENZYME INC.: DEALS 260
TABLE 255 AMANO ENZYME INC.: OTHERS 260
13.1.9 F. HOFFMANN-LA ROCHE LTD. 261
TABLE 256 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 261
FIGURE 70 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 262
TABLE 257 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262
TABLE 258 F. HOFFMANN-LA ROCHE LTD.: DEALS 264
13.1.10 NEW ENGLAND BIOLABS 265
TABLE 259 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW 265
TABLE 260 NEW ENGLAND BIOLABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 265
TABLE 261 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES 266
TABLE 262 NEW ENGLAND BIOLABS: DEALS 267
TABLE 263 NEW ENGLAND BIOLABS: OTHERS 268
13.1.11 BBI SOLUTIONS 269
TABLE 264 BBI SOLUTIONS: BUSINESS OVERVIEW 269
TABLE 265 BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
TABLE 266 BBI SOLUTIONS: DEALS 270
13.1.12 CREATIVE ENZYMES 272
TABLE 267 CREATIVE ENZYMES: BUSINESS OVERVIEW 272
TABLE 268 CREATIVE ENZYMES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272
13.1.13 BIOSEUTICA 274
TABLE 269 BIOSEUTICA: BUSINESS OVERVIEW 274
TABLE 270 BIOSEUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 274
TABLE 271 BIOSEUTICA: DEALS 275
13.1.14 SEKISUI DIAGNOSTICS 276
TABLE 272 SEKISUI DIAGNOSTICS: BUSINESS OVERVIEW 276
TABLE 273 SEKISUI DIAGNOSTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 276
TABLE 274 SEKISUI DIAGNOSTICS: OTHERS 277
13.1.15 ANTOZYME BIOTECH PVT. LTD. 279
TABLE 275 ANTOZYME BIOTECH PVT. LTD.: BUSINESS OVERVIEW 279
TABLE 276 ANTOZYME BIOTECH PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 279
13.2 OTHER PLAYERS 280
13.2.1 S.I. BIOZYME 280
TABLE 277 S.I. BIOZYME: BUSINESS OVERVIEW 280
TABLE 278 S.I. BIOZYME: PRODUCTS/SOLUTIONS/SERVICES OFFERED 280
13.2.2 AUMGENE BIOSCIENCES 281
TABLE 279 AUMGENE BIOSCIENCES: BUSINESS OVERVIEW 281
TABLE 280 AUMGENE BIOSCIENCES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
13.2.3 ENZYME BIOSCIENCE 283
TABLE 281 ENZYME BIOSCIENCE: BUSINESS OVERVIEW 283
TABLE 282 ENZYME BIOSCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283
13.2.4 INFINITA BIOTECH PRIVATE LIMITED 284
TABLE 283 INFINITA BIOTECH PRIVATE LIMITED: BUSINESS OVERVIEW 284
TABLE 284 INFINITA BIOTECH PRIVATE LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 284
13.2.5 BIOLAXI ENZYMES PVT. LTD. 285
TABLE 285 BIOLAXI ENZYMES PVT. LTD.: BUSINESS OVERVIEW 285
TABLE 286 BIOLAXI ENZYMES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
13.2.6 FIDO PHARMA PVT. LTD. 286
13.2.7 4BASEBIO 287
13.2.8 ANSEL BIOTECH 287
13.2.9 GENO TECHNOLOGY INC. 288
13.2.10 GUJARAT ENZYME 289
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 ADJACENT AND RELATED MARKETS 290
14.1 INTRODUCTION 290
TABLE 287 MARKETS ADJACENT TO SPECIALTY ENZYMES MARKET 290
14.2 LIMITATIONS 290
14.3 INDUSTRIAL ENZYMES MARKET 291
14.3.1 MARKET DEFINITION 291
14.3.2 MARKET OVERVIEW 291
TABLE 288 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2019–2022 (USD MILLION) 292
TABLE 289 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 292
TABLE 290 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2019–2022 (USD MILLION) 293
TABLE 291 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2023–2028 (USD MILLION) 293
14.4 FOOD ENZYMES MARKET 293
14.4.1 MARKET DEFINITION 293
14.4.2 MARKET OVERVIEW 294
14.4.3 FOOD ENZYMES MARKET, BY APPLICATION 294
TABLE 292 FOOD ENZYMES MARKET, BY TYPE, 2016–2020 (USD MILLION) 294
TABLE 293 FOOD ENZYMES MARKET, BY TYPE, 2021–2026 (USD MILLION) 295
14.4.4 FOOD ENZYMES MARKET, BY REGION 295
TABLE 294 FOOD ENZYMES MARKET, BY REGION, 2016–2020 (USD MILLION) 295
TABLE 295 FOOD ENZYMES MARKET, BY REGION, 2021–2026 (USD MILLION) 296
14.5 FEED ENZYMES MARKET 296
14.5.1 MARKET DEFINITION 296
14.5.2 MARKET OVERVIEW 296
TABLE 296 FEED ENZYMES MARKET, BY REGION, 2016–2019 (USD MILLION) 297
TABLE 297 FEED ENZYMES MARKET, BY REGION, 2020–2025 (USD MILLION) 297
15 APPENDIX 298
15.1 DISCUSSION GUIDE 298
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 303
15.3 CUSTOMIZATION OPTIONS 305
15.4 RELATED REPORTS 305
15.5 AUTHOR DETAILS 306
